Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...

NeoStem Receives Approval for Stem Cell Treatment

publication date: Nov 3, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
NeoStem announced its arthroscopic orthopedic treatment, which uses autologous adult stem cells, was approved by Weihai Municipal Price Bureau at Wendeng Orthopedic Hospital. At the same time, reimbursement for the procedure was approved by Weihai Municipal Labor Bureau Medical Insurance Office. Patients are eligible to receive reimbursement for up to 80% of the procedure’s cost. More details....

Stock Symbol: (NYSE Amex: NBS)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2013
  May 29-30, 2013
Beijing, China

>>More events...
Partner Events

China Medical Affairs Summit
  June 18-19, 2013
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners